Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells.

The mitogen-activated protein kinase (MAPK) signal transduction pathway plays an essential role in cell cycle progression and can be activated by many growth factor/mitogen pathways including estrogen. MAPK has also been implicated in ligand-independent activation of estrogen receptor-alpha (ER-alpha). The development of estrogen-independent growth in breast cancer is likely a first step in progression to hormone independence and antiestrogen resistance. We examined MAPK expression and activity in T5-PRF and T5 human breast cancer cells. T5-PRF is an estrogen-nonresponsive cell line developed from T5 cells by chronically depleting the cells of estrogen in long-term culture. MAPK activity measured in vitro was significantly higher (P < 0.05) in T5-PRF compared with T5 cells. Western blot analyses showed increased levels of active dually phosphorylated MAPK in T5-PRF cell extracts compared with T5. The increased activity and expression of MAPK may contribute to the estrogen nonresponsive growth phenotype and ligand-independent activity of ER in T5-PRF cells.

[1]  H. Greulich,et al.  An Analysis of Mek1 Signaling in Cell Proliferation and Transformation* , 1998, The Journal of Biological Chemistry.

[2]  D. Lannigan,et al.  Estradiol-induced Phosphorylation of Serine 118 in the Estrogen Receptor Is Independent of p42/p44 Mitogen-activated Protein Kinase* , 1998, The Journal of Biological Chemistry.

[3]  S. Kharbanda,et al.  Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis , 1997, Oncogene.

[4]  G. Nuovo,et al.  Hyperexpression of mitogen-activated protein kinase in human breast cancer. , 1997, The Journal of clinical investigation.

[5]  L. Murphy,et al.  Estrogen regulation of nuclear matrix‐intermediate filament proteins in human breast cancer cells , 1996, Journal of cellular biochemistry.

[6]  D. Picard,et al.  Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. , 1996, The EMBO journal.

[7]  P. Bontempo,et al.  Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells. , 1996, The EMBO journal.

[8]  Daniel Metzger,et al.  Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.

[9]  Philip R. Cohen,et al.  PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.

[10]  D. Heitjan,et al.  Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. , 1995, The Journal of clinical endocrinology and metabolism.

[11]  E. Krebs,et al.  The MAPK signaling cascade , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  S. F. Arnold,et al.  In vivo and in vitro phosphorylation of the human estrogen receptor , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  S. F. Arnold,et al.  Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro. , 1995, Molecular endocrinology.

[14]  S. F. Arnold,et al.  Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor. , 1994, Molecular endocrinology.

[15]  B. Katzenellenbogen,et al.  Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. , 1994, The Journal of biological chemistry.

[16]  L. Murphy,et al.  Enhanced c-jun activity alters responsiveness to medroxyprogesterone acetate in Ishikawa human endometrial carcinoma cells. , 1993, Molecular endocrinology.

[17]  E. Krebs,et al.  Identification of multiple epidermal growth factor-stimulated protein serine/threonine kinases from Swiss 3T3 cells. , 1990, The Journal of biological chemistry.

[18]  B. V. van Oirschot,et al.  Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue. , 1989, Cancer research.

[19]  A. Mérillat,et al.  Identification of estrogen-responsive DNA sequences by transient expression experiments in a human breast cancer cell line. , 1986, Nucleic acids research.

[20]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.